New York Announces One Month with COVID-19 Infection Rate Below 1 Percent - COVID-19 Clinical Trial
Breaking News | COVID-19

New York Announces One Month with COVID-19 Infection Rate Below 1 Percent

Governor Andrew M. Cuomo today announced for one month, or 31 days, that New York State’s COVID-19 infection rate has remained below 1 percent. Yesterday, 0.88 percent of tests reported to the state were positive. The number of new cases, percentage of tests that were positive and many other helpful data points are always available at

“Thanks to the hard work of New Yorkers, our state has now gone a full month with our COVID infection rate remaining below one percent,” Governor Cuomo said. “Our numbers have continued to remain stable even as we reach new milestones in our phased, data-driven reopening. As we close out this Labor Day Weekend, I urge everyone to remain smart so we can continue to celebrate our progress in the weeks and months ahead. It took the work of all of us to get here, and to protect this progress we will need to all continue to wash our hands, wear our masks, remain socially distant and above all, stay New York tough.”

AstraZeneca’s COVID-19 Vaccine to be Tested at Military Sites

Five Department of Defense facilities will participate in the Phase 3 trial of a COVID-19 vaccine, the Pentagon announced Thursday.According to the Department of Defense, researchers are still seeking volunteers for the next phase of testing for AZD1222, a COVID-19 vaccine candidate under development by AstraZeneca.

The upcoming trial will take place at Naval Medical Center in San Diego, Joint Base San Antonio, Wilford Hall Ambulatory Surgical Center in San Diego, Walter Reed National Military Medical Center in Bethesda, Md., and Fort Belvoir Community Hospital in Fort Belvoir, Virginia.”The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” Tom McCaffery, assistant secretary of defense for health affairs, said in a statement.

Share this:

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.

Want to stay informed?

With an ever-changing situation like COVID-19, it’s important to stay as tuned in as possible. Submit your information below so we can send you periodic updates.